ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prothrombin Complex Concentrate (PCC) Drug Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-20A10685
Home | Market Reports | Health| Pharmacy
Global Prothrombin Complex Concentrate PCC Drug Market Research Report 2022
BUY CHAPTERS

Global Prothrombin Complex Concentrate (PCC) Drug Market Research Report 2025

Code: QYRE-Auto-20A10685
Report
March 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
Octapharma AG
CSL Behring
Grifols S A
Prothya Biosolutions

Prothrombin Complex Concentrate (PCC) Drug Market

The global market for Prothrombin Complex Concentrate (PCC) Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
In Europe and United States market, key players of prothrombin complex concentrate (PCC) drug include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. The top one player hold a share about 58%. United States is the largest market, has a share about 47%, followed by Germany, and France, with share 13% and 12%, separately.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prothrombin Complex Concentrate (PCC) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prothrombin Complex Concentrate (PCC) Drug.
The Prothrombin Complex Concentrate (PCC) Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prothrombin Complex Concentrate (PCC) Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prothrombin Complex Concentrate (PCC) Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prothrombin Complex Concentrate (PCC) Drug Market Report

Report Metric Details
Report Name Prothrombin Complex Concentrate (PCC) Drug Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prothrombin Complex Concentrate (PCC) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prothrombin Complex Concentrate (PCC) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the Prothrombin Complex Concentrate (PCC) Drug Market share by region?

Ans: United States is the largest market, has a share about 47%, followed by Germany, and France, with share 13% and 12%, separately.

Who are the main players in the Prothrombin Complex Concentrate (PCC) Drug Market report?

Ans: The main players in the Prothrombin Complex Concentrate (PCC) Drug Market are CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda

What are the Application segmentation covered in the Prothrombin Complex Concentrate (PCC) Drug Market report?

Ans: The Applications covered in the Prothrombin Complex Concentrate (PCC) Drug Market report are Hemophilia B, Acquired Coagulation Factor Deficiency

What are the Type segmentation covered in the Prothrombin Complex Concentrate (PCC) Drug Market report?

Ans: The Types covered in the Prothrombin Complex Concentrate (PCC) Drug Market report are Beriplex, Profilnine, Octaplex, Prothromplex, Cofact, Other

Recommended Reports

Coagulation Disorder Drugs

Hemophilia & Bleeding Management

Thrombosis & Anticoagulants

1 Prothrombin Complex Concentrate (PCC) Drug Market Overview
1.1 Product Definition
1.2 Prothrombin Complex Concentrate (PCC) Drug by Type
1.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Beriplex
1.2.3 Profilnine
1.2.4 Octaplex
1.2.5 Prothromplex
1.2.6 Cofact
1.2.7 Other
1.3 Prothrombin Complex Concentrate (PCC) Drug by Application
1.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Application (2024 VS 2031)
1.3.2 Hemophilia B
1.3.3 Acquired Coagulation Factor Deficiency
1.4 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Estimates and Forecasts
1.4.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue 2020-2031
1.4.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales 2020-2031
1.4.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prothrombin Complex Concentrate (PCC) Drug Market Competition by Manufacturers
2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prothrombin Complex Concentrate (PCC) Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Product Type & Application
2.7 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Date of Enter into This Industry
2.8 Global Prothrombin Complex Concentrate (PCC) Drug Market Competitive Situation and Trends
2.8.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prothrombin Complex Concentrate (PCC) Drug Players Market Share by Revenue
2.8.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prothrombin Complex Concentrate (PCC) Drug Market Scenario by Region
3.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2020-2031
3.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2020-2025
3.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2026-2031
3.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2020-2031
3.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2020-2025
3.3.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2026-2031
3.4 North America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.4.1 North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2031)
3.4.3 North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.5.1 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2031)
3.5.3 Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.7.1 Latin America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2031)
3.7.3 Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2020-2031)
4.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2020-2025)
4.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2026-2031)
4.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2020-2031)
4.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2020-2031)
4.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2020-2025)
4.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2026-2031)
4.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2020-2031)
4.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2020-2031)
5.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2020-2025)
5.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2026-2031)
5.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2020-2031)
5.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2020-2031)
5.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2020-2025)
5.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2026-2031)
5.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2020-2031)
5.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Octapharma
6.3.1 Octapharma Company Information
6.3.2 Octapharma Description and Business Overview
6.3.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.3.5 Octapharma Recent Developments/Updates
6.4 Prothya Biosolutions
6.4.1 Prothya Biosolutions Company Information
6.4.2 Prothya Biosolutions Description and Business Overview
6.4.3 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.4.5 Prothya Biosolutions Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Company Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.5.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain Analysis
7.2 Prothrombin Complex Concentrate (PCC) Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prothrombin Complex Concentrate (PCC) Drug Production Mode & Process Analysis
7.4 Prothrombin Complex Concentrate (PCC) Drug Sales and Marketing
7.4.1 Prothrombin Complex Concentrate (PCC) Drug Sales Channels
7.4.2 Prothrombin Complex Concentrate (PCC) Drug Distributors
7.5 Prothrombin Complex Concentrate (PCC) Drug Customer Analysis
8 Prothrombin Complex Concentrate (PCC) Drug Market Dynamics
8.1 Prothrombin Complex Concentrate (PCC) Drug Industry Trends
8.2 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
8.3 Prothrombin Complex Concentrate (PCC) Drug Market Challenges
8.4 Prothrombin Complex Concentrate (PCC) Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Takeda
Octapharma AG
CSL Behring
Grifols S A
Prothya Biosolutions
List of Tables
 Table 1. Global Prothrombin Complex Concentrate (PCC) Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prothrombin Complex Concentrate (PCC) Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prothrombin Complex Concentrate (PCC) Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prothrombin Complex Concentrate (PCC) Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prothrombin Complex Concentrate (PCC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prothrombin Complex Concentrate (PCC) Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. CSL Behring Company Information
 Table 71. CSL Behring Description and Business Overview
 Table 72. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product
 Table 74. CSL Behring Recent Developments/Updates
 Table 75. Grifols Company Information
 Table 76. Grifols Description and Business Overview
 Table 77. Grifols Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Grifols Prothrombin Complex Concentrate (PCC) Drug Product
 Table 79. Grifols Recent Developments/Updates
 Table 80. Octapharma Company Information
 Table 81. Octapharma Description and Business Overview
 Table 82. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product
 Table 84. Octapharma Recent Developments/Updates
 Table 85. Prothya Biosolutions Company Information
 Table 86. Prothya Biosolutions Description and Business Overview
 Table 87. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product
 Table 89. Prothya Biosolutions Recent Developments/Updates
 Table 90. Takeda Company Information
 Table 91. Takeda Description and Business Overview
 Table 92. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Takeda Prothrombin Complex Concentrate (PCC) Drug Product
 Table 94. Takeda Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Prothrombin Complex Concentrate (PCC) Drug Distributors List
 Table 98. Prothrombin Complex Concentrate (PCC) Drug Customers List
 Table 99. Prothrombin Complex Concentrate (PCC) Drug Market Trends
 Table 100. Prothrombin Complex Concentrate (PCC) Drug Market Drivers
 Table 101. Prothrombin Complex Concentrate (PCC) Drug Market Challenges
 Table 102. Prothrombin Complex Concentrate (PCC) Drug Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prothrombin Complex Concentrate (PCC) Drug
 Figure 2. Global Prothrombin Complex Concentrate (PCC) Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Type: 2024 & 2031
 Figure 4. Beriplex Product Picture
 Figure 5. Profilnine Product Picture
 Figure 6. Octaplex Product Picture
 Figure 7. Prothromplex Product Picture
 Figure 8. Cofact Product Picture
 Figure 9. Other Product Picture
 Figure 10. Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Application: 2024 & 2031
 Figure 12. Hemophilia B
 Figure 13. Acquired Coagulation Factor Deficiency
 Figure 14. Global Prothrombin Complex Concentrate (PCC) Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Prothrombin Complex Concentrate (PCC) Drug Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Prothrombin Complex Concentrate (PCC) Drug Sales (2020-2031) & (K Units)
 Figure 17. Global Prothrombin Complex Concentrate (PCC) Drug Average Price (US$/Unit) & (2020-2031)
 Figure 18. Prothrombin Complex Concentrate (PCC) Drug Report Years Considered
 Figure 19. Prothrombin Complex Concentrate (PCC) Drug Sales Share by Manufacturers in 2024
 Figure 20. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Prothrombin Complex Concentrate (PCC) Drug Players: Market Share by Revenue in Prothrombin Complex Concentrate (PCC) Drug in 2024
 Figure 22. Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2020-2031)
 Figure 25. North America Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2020-2031)
 Figure 26. United States Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2020-2031)
 Figure 29. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2020-2031)
 Figure 37. China Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type (2020-2031)
 Figure 56. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Prothrombin Complex Concentrate (PCC) Drug by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Prothrombin Complex Concentrate (PCC) Drug by Application (2020-2031)
 Figure 59. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Application (2020-2031)
 Figure 60. Prothrombin Complex Concentrate (PCC) Drug Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Prothrombin Complex Market Research Report 2024
Human Prothrombin Complex Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Prothrombin Complex Market Research Report 2025
Global Precipitated Calcium Carbonate PCC for Adhesives Sealants Market Research Report 2025
Global Anticoagulant Citrate Phosphate Dextrose Solution CPD Market Research Report 2025
Global Coagulation Factor Concentrates Market Research Report 2024
Global Carboplatin Market Research Report 2025
Factor IX Complex Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
4 Factor Pro thrombin Complex Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prothrombin Complex Concentrate PCC Market Research Report 2024
Global Ultra fine Precipitated Calcium Carbonate PCC Market Research Report 2025
Global Activated Prothrombin Complex Concentrate aPCC Market Research Report 2024
Global Activated Partial Thromboplastin Market Research Report 2024
Prothrombin Time Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Activated Protein C Market Research Report 2025
Global Point of Care POC Coagulation Analyzer Market Research Report 2025
Global Coagulation POC Analyzer Market Research Report 2025
Global POC Coagulation Analyzer Market Research Report 2025
Global PCT Chamber Market Research Report 2024
Global Thrombin Preparation Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions